Global Times: Chinese insurers pursue innovative programs to shore up elderly care
BEIJING, Oct. 25, 2024 /PRNewswire/ -- Pension finance has been elevated to a strategic priority since the Central Financial Work Conference held in 2023 outlined the industry as one of the five most important areas for the high-quality development of the country's financial sector. In recent years, Chinese financial institutions, especially life insurers, boosted the innovative development of the...
Ribbon of Hope: A Collaborative Cancer Support Initiative by BIG Pharmacy and CARiNG Pharmacy
JOHOR BAHRU, Malaysia, Oct. 25, 2024 /PRNewswire/ -- BIG CARiNG Group proudly announces the unveiling of its revolutionary Cancer Support Program, namely "Ribbon of Hope" for you and those you care for at the Biggest Health & Beauty Expo held at Mid Valley Southkey. This initiative is designed to support cancer patients and their caregivers throughout their cancer journey, addressing...
TASTE-2 World Stroke Congress | Sanbexin ® combined with thrombectomy significantly reduces stroke disability
NANJING, China, Oct. 25, 2024 /PRNewswire/ -- On October 24, 2024, TASTE-2, a Chinese innovative stroke drug study led by Professor Wang Yongjun from Beijing Tiantan Hospital, was published in an oral report at the 16th World Stroke Conference (WSC): brain cell protection combined with edaravone dexborneol (Sanbexin ®) in patients with acute ischemic stroke before endovascular thrombectomy significantly improved...
Sky Labs’ Blood Pressure Monitoring Device Recognized for High Accuracy by the International Society of Hypertension
SEOUL, South Korea, Oct. 25, 2024 /PRNewswire/ -- Sky Labs' CART BP, an innovative blood pressure monitoring device, has been recognized by the International Society of Hypertension (ISH) for its exceptional accuracy in both day and night measurements. This recognition, prominently featured in an official position paper led by Professor Kazuomi Kario of Japan's Jichi Medical University, underscores the...
Everest Medicines Announces the Launch of VELSIPITY® in the Guangdong-Hong Kong-Macau Greater Bay Area, Offering a New Option for Moderately to Severely Active Ulcerative Colitis Patients
SHANGHAI, Oct. 25, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that, through the "Hong Kong and Macau Medicine and Equipment Connect" policy, VELSIPITY® has officially been approved for patients with moderately to severely active ulcerative colitis (UC) by the...
Volpara Health Surpasses 300 Peer-Reviewed Papers
Milestone reinforces readership in AI-powered breast cancer detection WELLINGTON, New Zealand, Oct. 25, 2024 /PRNewswire/ -- Volpara Health, a Lunit company and global leader in artificial intelligence (AI)-powered breast health solutions, has reached a significant milestone: the publication of the 300th peer-reviewed scientific paper using Volpara results. This accomplishment underscores Volpara's commitment...
Shaklee, A Leader in Clean Wellness and Skincare, Expands into Australia
The Brand Ushers in a New Era of Growth as It Approaches Its 75th Anniversary MIAMI, Oct. 24, 2024 /PRNewswire/ -- Shaklee, a leading health and wellness company, whose founder invented the first multivitamin in the U.S., is launching in its newest international market: Australia. The news comes as the brand builds on the significant momentum it's seeing in...
Frost & Sullivan Honors Industry Leaders with Prestigious 2024 Best Practices Awards
Top Innovators Recognized for Outstanding Achievements at Semiannual Awards Gala SAN ANTONIO, Oct. 24, 2024 /PRNewswire/ -- The 2024 Frost & Sullivan Best Practices Awards Gala, hosted at the JW Marriott Tucson Starr Pass Resort in Tucson, AZ, brought together the best in business to celebrate trailblazing companies. The event honored organizations that have demonstrated exceptional innovation, leadership, and business...
EpiVax and CUBRC Awarded FDA Contract Worth $2M for Development of Control Peptides for Immunogenicity Risk Assessment Assays Supporting Regulatory Filings of Generic Peptide Drugs
PROVIDENCE, R.I., Oct. 24, 2024 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") and CUBRC, Inc. ("CUBRC") announce today that they have been awarded a two-year, $2 million contract (#75F40124C00094) from the Office of Generic Drugs (OGD) of the Food and Drug Administration (FDA) to develop standardized controls for T cell assays performed to assess...
IMG Announces 2024 Leave Your Mark Grant Winners
INDIANAPOLIS, Oct. 24, 2024 /PRNewswire/ -- IMG (International Medical Group), an award-winning global insurance benefits and assistance services company, is excited to announce the winners of its eighth annual Leave Your Mark Grant. This year, more than 800 organizations and individuals submitted entries, making it the largest applicant pool in the history...
